Stockscreener 앱 받기
14.87
0.60%
-0.09
시간 외 거래:
14.88
0.01
+0.07%
전일 마감가:
$14.96
열려 있는:
$14.96
하루 거래량:
27.29M
Relative Volume:
8.74
시가총액:
$2.21B
수익:
-
순이익/손실:
$-174.61M
주가수익비율:
-7.5482
EPS:
-1.97
순현금흐름:
$-165.54M
1주 성능:
+84.26%
1개월 성능:
+65.22%
6개월 성능:
+69.17%
1년 성능:
+79.37%
1일 변동 폭
$14.83
$15.00
1주일 범위
$7.835
$15.06
52주 변동 폭
$4.16
$15.06
89 Bio Inc Stock (ETNB) Company Profile
명칭
89 Bio Inc
전화
(415) 432-9270
주소
655 MONTGOMERY STREET, SAN FRANCISCO, CA
ETNB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
14.87 | 2.22B | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 재개 | H.C. Wainwright | Buy |
| 2025-03-14 | 개시 | Goldman | Neutral |
| 2025-03-13 | 개시 | Citigroup | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2024-04-22 | 재개 | BofA Securities | Buy |
| 2024-01-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2023-08-28 | 개시 | UBS | Buy |
| 2023-06-13 | 개시 | Evercore ISI | Outperform |
| 2022-05-12 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-12-20 | 개시 | H.C. Wainwright | Buy |
| 2021-10-26 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-07-29 | 재개 | BTIG Research | Buy |
| 2021-05-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-10-19 | 개시 | Raymond James | Strong Buy |
| 2020-09-25 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-31 | 개시 | Piper Sandler | Overweight |
| 2020-07-23 | 개시 | BTIG Research | Buy |
| 2020-07-07 | 개시 | Chardan Capital Markets | Buy |
| 2019-12-09 | 개시 | BofA/Merrill | Neutral |
| 2019-12-09 | 개시 | Oppenheimer | Outperform |
| 2019-12-09 | 개시 | RBC Capital Mkts | Outperform |
| 2019-12-09 | 개시 | SVB Leerink | Outperform |
모두보기
89 Bio Inc 주식(ETNB)의 최신 뉴스
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PGRE, ETNB, STAA on Behalf of Shareholders - GlobeNewswire Inc.
89Bio (ETNB) Soars 86 Percent to Historic High on $3.5-Billion Roche Merger - MSN
Will 89bio Inc. continue its uptrendPortfolio Update Summary & Verified High Yield Trade Plans - newser.com
Published on: 2025-09-19 14:02:20 - newser.com
Has 89bio Inc. found a price floor2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
89bio Stock Price, Quotes and Forecasts | NASDAQ:ETNB - Benzinga
89BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc.ETNB - Business Wire
Dow Update: Is 89bio Inc trading at a discountWeekly Trade Analysis & Reliable Price Breakout Alerts - khodrobank.com
Roche to Buy 89bio for Up to $3.5 Billion in Obesity Push - MSN
Measuring 89bio Inc.’s beta against major indices2025 Top Gainers & Free Technical Pattern Based Buy Signals - newser.com
89bio Inc. stock chart pattern explainedMarket Growth Summary & AI Forecast for Swing Trade Picks - newser.com
Roche Makes Major MASH Bid, Offering $2.4bn For 89Bio - insights.citeline.com
Roche’s 89bio Buyout: Building A Combo-Ready Metabolic Franchise Beyond GLP-1 Wars (RHHBY) - Seeking Alpha
89bio: Pegozafermin MASH Drug Advancement Nets Roche Acquisition (NASDAQ:ETNB) - Seeking Alpha
Roche To Buy 89bio in $3.5 Billion Deal - USA Herald
Roche To Acquire 89bio For $2.4 Billion In Liver And Cardiometabolic Push - Benzinga
Roche Expands Cardiometabolic Pipeline With 89bio Acquisition (OTCMKTS:RHHBY) - Seeking Alpha
RHHBY to Acquire 89bio for $3.5B, Add Late-Stage MASH Drug to Pipeline - Yahoo Finance
MASH dash speeds up as Roche acquires 89bio for up to $3.5B - BioWorld MedTech
Roche deal to buy 89bio boosts MASH space (ETNB:NASDAQ) - Seeking Alpha
Roche to Buy Maker of Fatty Liver Treatment 89bio for Up to $3.5 Billion - The Wall Street Journal
Roche to acquire liver drug developer 89bio for up to $3.5 billion - Reuters
ETNB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 89bio, Inc. Is Fair to Shareholders - Business Wire
Roche to Buy Biopharmceutical Firm 89bio in $3.5 Billion Deal - Bloomberg.com
Roche Holding AG agreed to acquire 89bio, Inc. for $2.2 billion in a tender offer transaction. - MarketScreener
Shareholder Alert: The Ademi Firm Investigates Whether 89bio, Inc. is Obtaining a Fair Price for its Public Shareholders - Business Wire
89bio, Inc. Announces Agreement to be Acquired by Roche - The Manila Times
$3.5 Billion Biotech Deal: Roche Acquires 89bio for Breakthrough MASH Treatment Pegozafermin - Stock Titan
Roche enters into a definitive merger agreement to acquire - GlobeNewswire
Using portfolio simulators with 89bio Inc. includedJuly 2025 Trends & Long-Term Capital Growth Strategies - newser.com
98,848 Shares in 89BIO $ETNB Acquired by Jacobs Levy Equity Management Inc. - MarketBeat
Stock Recap: What are LENZs recent SEC filings showingJuly 2025 Opening Moves & Smart Investment Allocation Tips - خودرو بانک
Visual trend scoring systems applied to 89bio Inc.July 2025 Selloffs & Verified Momentum Stock Ideas - newser.com
Applying chart zones and confluence areas to 89bio Inc.2025 Key Lessons & Weekly Top Gainers Trade List - newser.com
Risk Off: Does 89bio Inc. have a sustainable dividendIndex Update & Weekly Setup with ROI Potential - khodrobank.com
Goldman Sachs Group Inc. Has $7.24 Million Position in 89BIO $ETNB - MarketBeat
Is 89bio Inc. trending in predictive chart modelsTrade Analysis Report & Community Consensus Trade Signals - newser.com
How to escape a deep drawdown in 89bio Inc.2025 Support & Resistance & Fast Gain Swing Alerts - newser.com
measuring 89bio inc.’s beta against major indicesWeekly Risk Summary & Weekly Watchlist for Consistent Profits - newser.com
Candlestick signals on 89bio Inc. stock todayPortfolio Profit Report & Breakout Confirmation Alerts - newser.com
Real time alert setup for 89bio Inc. performanceBuy Signal & Expert Curated Trade Ideas - newser.com
89 Bio Inc (ETNB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.43%
0.09%
자본화:
|
볼륨(24시간):